Fanconi Anemia as a Window into Premalignant Field Cancerization of the Oral Mucosa
Berger, T.; Donovan, F. X.; Lin, Y.-C.; Soma, S.; May, F.; Bhadresha, K.; Krieg, C.; Giri, N.; McReynolds, L. J.; Filie, A.; Khavandgar, Z.; Laronde, D. M.; Guillaud, M.; Savage, S. A.; Kutler, D. I.; Crismani, W.; Velleuer, E.; Uppgaard, R.; Harper, U. L.; Alston, K. O.; Thomas, J. W.; Auerbach, A. D.; Chandrasekharappa, S. C.; Smogorzewska, A.
Show abstract
Head and neck squamous cell carcinoma (HNSCC) evolves through stepwise clonal expansion within genetically altered mucosa fields, yet actionable biomarkers remain undefined. Leveraging Fanconi anemia (FA), a cancer predisposition syndrome with extreme HNSCC risk due to defective DNA interstrand crosslink repair, we profiled premalignant changes in the oral cavity using noninvasive brush biopsies. Consistent with our prior demonstration of genomic instability in FA-associated SCCs, we detected pathogenic TP53 variants in 26% and copy number alterations in 60.5% in clinically normal-appearing oral mucosa of individuals with FA. These subclinical clonal expansions define candidate biomarkers of early clonal evolution amenable to serial sampling for risk stratification and prevention studies. Since FA-associated SCCs share genomic features with sporadic HNSCC, these findings may extend to the broader population. We also identify somatic reversion of a pathogenic FANCB variant, providing evidence of genomic self-correction and suggesting a potential avenue for gene-based cancer prevention in FA.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.